| Topics
Ask the Doctor: Want to know more about a specific topic? Click here to contact us and let us know.
|
SO LONG HOSPITAL |
| The hospital has become an institution dedicated to the service of the surgeons and hospital based physcians. |
|
INSURANCE COMPANIES |
| Did you ever wonder why certain doctors belong to different insurance company plans? And specifically, did you ever wonder why Dr. Beene did not belong to your plan? If you belong to the Northeast Louisiana PHO, you may want to read this!!! |
|
Air Travel and Blood Clots |
| NEW YORK (Reuters Health) - Immobilization alone does not explain the increased risk of venous thrombosis after prolonged air travel, Dutch investigators report. Factors associated with flight -- most likely low barometric pressure and low oxygen levels -- increase markers of coagulation activation, they found. |
|
Byetta for Type II diabetes |
| Byetta, made from the saliva of the Gila monster lizard, is the first in a new class of medicines known as incretin mimetics, a new class of therapeutics for use in treating type 2 diabetes. |
|
Inhaled insulin |
| Long-term glycemic control substantially reduces the risk of diabetes mellitus-related complications. Insulin is a mainstay in therapy in type 1 and later-stage type 2 diabetes mellitus. Although insulin is effective in controlling blood glucose and hemoglobin A1c concentrations, the need for subcutaneous injection can be a burden for patients, which can impact compliance. Exubera (Nektar Therapeutics/Pfizer/Sanofi-Aventis) is an inhaled insulin that has demonstrated results similar to conventional short-acting insulin products while also increasing overall patient satisfaction. If approved, Exubera would be the first non-injectable insulin available in the United States. The product is administered as a dry powder fast-acting form of insulin via oral inhalation. FDA's Endocrinologic and Metabolic Drugs Advisory Committee recommended Exubera for approval in early September 2005. Exubera may offer an excellent alternative for patients suffering from diabetes who for health, personal, or societal reasons have difficulty administering subcutaneous insulin. |
|
Diabetic diets |
| The two major forms of diabetes are type 1, previously called insulin-dependent diabetes mellitus (IDDM) or juvenile-onset diabetes, and type 2, previously called non-insulin-dependent diabetes mellitus (NIDDM) or maturity-onset diabetes. [For more details, see Well-Connected Report #9 Diabetes Type 1and Report #60 Diabetes Type 2.] |
View our Topic Archives
|
